Artificial Intelligence and Technology Collaboratory
ID: 359654Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to announce a funding opportunity for the Artificial Intelligence and Technology Collaboratory (AITC) Program, aimed at advancing research in aging and Alzheimer's disease through innovative AI and technology solutions. This program seeks applications from small businesses to develop and implement AI approaches while addressing ethical challenges and promoting best practices in aging research. The AITC Program will serve as a national resource, supporting collaborative teams across various disciplines to tackle emerging priorities in the field. Interested applicants should note that applications are not currently being solicited, but they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 15, 2025, and a closing date of October 15, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Krupenevich at NIAAITC@nih.gov.

    Point(s) of Contact
    Rebecca Krupenevich, Ph.D. National Institute on Aging (NIA)
    N/A
    NIAAITC@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Artificial Intelligence and Technology Collaboratory Coordinating Center
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming opportunity for a Cooperative Agreement to establish the Artificial Intelligence and Technology Collaboratory Coordinating Center (AITCC) under the National Institute on Aging (NIA). This initiative aims to promote the development and implementation of artificial intelligence (AI) and technology approaches to advance research in aging, Alzheimer's disease (AD), and related dementias (ADRD), fostering collaboration among diverse stakeholders in academia, non-profit, and healthcare sectors. The AITCC will serve as a national resource, facilitating research projects and addressing algorithmic fairness in AI applications for individuals experiencing cognitive decline. Interested small businesses are encouraged to prepare for the application process, with the estimated synopsis posting date on August 15, 2025, and a closing date of October 15, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Krupenevich at NIAAITC@nih.gov.
    Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Alzheimer's Clinical Trials Consortium (ACTC) aimed at developing and implementing multi-site Phase Ib to III clinical trials for interventions targeting Alzheimer's disease (AD) and related dementias (ADRD). This initiative seeks to foster collaborative efforts between applicants, the National Institute on Aging (NIA), and the ACTC network to test promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat symptoms associated with AD and ADRD. The funding opportunity, utilizing the R01 activity code, is particularly significant as it addresses the growing need for effective treatments for age-related cognitive decline. Interested small businesses are encouraged to prepare for application submission, with the estimated synopsis post date on August 1, 2025, and a closing date of October 5, 2025. For further inquiries, potential applicants can contact Laurie Ryan, Ph.D., at 301-496-9350 or via email at ryanl@mail.nih.gov.
    New NIA Institutional Training Programs for Aging Research
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "New NIA Institutional Training Programs for Aging Research," aimed at developing and expanding a trained workforce in scientific disciplines related to aging research. This grant will support the establishment of new institutional predoctoral and/or postdoctoral training programs in high-priority areas, covering costs such as stipends, tuition, fees, and training-related expenses for selected trainees, while excluding programs focused on Alzheimer's disease and similar initiatives already funded at the applicant institution. Interested small businesses are encouraged to prepare for this opportunity, with an estimated synopsis posting date of October 1, 2025, and a closing date for applications expected by May 25, 2026; for further inquiries, contact Dr. Laura Major at NIATraining@mail.nih.gov or call 301-827-4464.
    Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting early- and late-stage clinical trials focused on Alzheimer's Disease (AD), Alzheimer's Disease-Related Dementias (ADRD), and age-related cognitive decline. This initiative seeks applications that propose innovative pharmacological and non-pharmacological interventions to address cognitive, behavioral, and neuropsychiatric changes associated with these conditions, as well as studies to enhance trial design and methodologies. The funding opportunity, categorized under health-related discretionary grants, is intended for small businesses with expertise in aging research, with an estimated synopsis posting date of August 1, 2025, and a closing date for applications expected by October 5, 2025. For further inquiries, interested applicants can contact Laurie Ryan, Ph.D., at 301-496-9350 or via email at ryanl@mail.nih.gov.
    National Alzheimer’s Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the establishment of a National Alzheimer's Coordinating Center (NACC) under a cooperative agreement. The NACC aims to serve as a national data resource for Alzheimer's disease and related dementias (AD/ADRD) research, facilitating data collection from Alzheimer’s Disease Research Centers (ADRCs) and enhancing communication within the ADRC program. This initiative is crucial for advancing research in the field of aging and dementia, providing a centralized hub for collaboration and data sharing. Interested small businesses are encouraged to prepare for the application process, with the estimated synopsis posting date on August 15, 2025, and the anticipated award date set for July 15, 2026. For further inquiries, potential applicants can contact Dr. Cerise Elliott at elliottce@nih.gov or by phone at 301-496-9350.
    Dementia Care and Caregiver Support Intervention Research - Stages II - V
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for research applications focused on developing behavioral interventions for individuals living with Alzheimer's disease and related dementias, as well as their caregivers. This initiative aims to support a milestone-driven planning phase lasting up to two years, with the potential for transition to a clinical trial phase upon successful completion of the required milestones. The funding opportunity is particularly significant as it addresses critical health challenges associated with aging and dementia care. Interested small businesses are encouraged to prepare for this opportunity, with the estimated synopsis posting date set for November 1, 2025, and applications expected to close by February 16, 2026. For further inquiries, potential applicants can contact Dr. Melissa Riddle at melissa-riddle@nih.gov or by phone at 301-480-6761.
    Notice of Intent to Publish a Notice of Funding Opportunity for Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Alzheimer’s Clinical Trials Consortium (ACTC) aimed at developing and implementing multi-site Phase Ib to III clinical trials for interventions targeting Alzheimer’s disease (AD) and related dementias (ADRD). This initiative seeks applications for promising pharmacological and non-pharmacological strategies that may prevent, delay, or treat the symptoms of AD, utilizing the ACTC's trial coordination and management infrastructure. The NOFO is significant as it addresses a critical health challenge, and it is expected to be published in December 2024, with application due dates in March, June, and October of 2025. Interested applicants should prepare for the R01 activity code funding, with an estimated award date set for December 1, 2025.
    PRIMED-AI: Translating Models to Clinic (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "PRIMED-AI: Translating Models to Clinic," aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative, part of the Precision Medicine with Artificial Intelligence program, will utilize a biphasic mechanism focusing initially on rigorous AI model building through the analysis of large datasets, with successful projects advancing to evaluate the clinical utility of AI-driven Clinical Decision Support tools. The estimated total program funding is $10.2 million, with applications expected to be solicited after the synopsis posting on July 1, 2025, and a closing date anticipated on November 1, 2025. Interested applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.
    Dementia Care and Caregiver Support Intervention Research - Stage I Only
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Dementia Care and Caregiver Support Intervention Research - Stage I Only," aimed at supporting research focused on developing behavioral interventions for individuals living with Alzheimer's disease and related dementias, as well as their caregivers. This initiative will utilize the R34 activity code and is designed to facilitate the development, modification, and refinement of principle-based behavioral interventions, ensuring their acceptability and feasibility in preparation for later-stage clinical trials. Interested small businesses are encouraged to begin forming collaborations and developing project proposals, with the estimated synopsis posting date on November 1, 2025, and a closing date for applications expected by February 16, 2026. For further inquiries, potential applicants can contact Melissa Riddle, Ph.D., at melissa-riddle@nih.gov or by phone at 301-480-6761.
    Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the establishment of a Data Coordinating Center dedicated to the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA). This initiative aims to integrate and disseminate multiscale mouse brain datasets to support the aging and Alzheimer’s disease research community, leveraging the NIA-supported AD Knowledge Portal for data hosting and collaborative analyses, while also developing tools for the integration of multi-omics and connectomics datasets. The opportunity is particularly significant as it will serve as a central resource for researchers, enhancing the accessibility and visualization of integrated data. Interested applicants, particularly small businesses with expertise in aging research, are encouraged to prepare for the application process, with the estimated synopsis post date set for September 1, 2025, and the application deadline anticipated for January 25, 2026. For further inquiries, potential applicants can contact Erin E. Gray, Ph.D., at erin.gray@nih.gov or by phone at 301-451-3968.